Multidisciplinary treatment of locally advanced rectal cancer: A literature review. Part 1

Expert Opinion on Pharmacotherapy

Volumn 10, Issue 14, 2009, Pages 2245-2258

  Berardi, Rossana ^a   Maccaroni, Elena ^a   Onofri, Azzurra ^a   Giampieri, Riccardo ^a   Bittoni, Alessandro ^a   Pistelli, Mirco ^a   Scartozzi, Mario ^a   Pierantoni, Chiara ^a   Bianconi, Maristella ^a   Cascinu, Stefano ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Locally advanced rectal cancer; Neoadjuvant treatment; Radiochemotherapy; Target drugs

Indexed keywords

ANTINEOPLASTIC AGENT; BEVACIZUMAB; CALCIUM; CAPECITABINE; CETUXIMAB; FLUOROPYRIMIDINE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; MONOCLONAL ANTIBODY; OXALIPLATIN; PROTEIN TYROSINE KINASE INHIBITOR;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADVANCED CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL PRACTICE; CLINICAL TRIAL; COLORECTAL CANCER; GASTROINTESTINAL SYMPTOM; HUMAN; INTERMETHOD COMPARISON; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PATIENT COMPLIANCE; POSTOPERATIVE CARE; PREOPERATIVE CARE; PREOPERATIVE PERIOD; PROGNOSIS; QUALITY OF LIFE; RADIATION DOSE; RECTUM CANCER; RECTUM CARCINOMA; REVIEW; UNSPECIFIED SIDE EFFECT;

ADENOCARCINOMA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; HUMANS; NEOADJUVANT THERAPY; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECTAL NEOPLASMS; SURVIVAL RATE;

EID: 70349404394     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656560903143776     Document Type: Review

References (63)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin 2008;58:71-96
2. Martling AL, Holm T, Rutqvist LE, et al. Effect of a surgical training programme on outcome of rectal cancer in the county of Stockholm. Lancet 2000;356:93-96 (Pubitemid 30438509)
3. Krook JE, Moertel CG, Gunderson LL, et al. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 1991;324:709-715
4. NIH Consensus Conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA 1990;264:1444-1450 (Pubitemid 20331943)
5. Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative radiotherapy for rectal cancer. N Engl J Med 2004;351:1731-1740 •• Preoperative chemoradiotherapy, compared with postoperative chemoradiotherapy, improved local control and was associated with reduced toxicity but did not improve overall survival.
6. Minsky BD. Adjuvant therapy for rectal cancer. ASCO Annual Meeting Educational Book. J Clin Oncol 2002;20:472-477
7. Willett CG, Badizadegan K, Ancukiewicz M, et al. Prognostic factors in stage T3N0 rectal cancer: do all patients require postoperative pelvic irradiation and chemotherapy? Dis Colon Rectum 1999;42:167-173
8. Madoff RD. Chemoradiotherapy for rectal cancer - when, why, and how? N Engl J Med 2004;351:1790-1792
9. Minsky BD, Cohen AM, Kemeny N, et al. Enhancement of radiation-induced downstaging of rectal cancer by fluorouracil and high-dose leucovorin chemotherapy. J Clin Oncol 1992;10:79-84
10. Bosset JF, Magnin V, Maingon P, et al. Preoperative radiochemotherapy in rectal cancer: long-term results of a phase II trial. Int J Radiat Oncol Biol Phys 2000;46:323-327 (Pubitemid 30067781)
11. Marijnen CA, van de Velde CJ, Putter H, et al. Impact of short-term preoperative radiotherapy on health-related quality of life and sexual functioning in primary rectal cancer: report of a multicenter randomized trial. J Clin Oncol 2005;23:1847-1858 (Pubitemid 46211362)
12. Pollack J, Holm T, Cedermark B, et al. Long-term effect of preoperative radiation therapy on anorectal function. Dis Colon Rectum 2006;49:345-352
13. Hendren SK, Swallow CJ, Smith A, et al. Prevalence of male and female sexual dysfunction is high following surgery for rectal cancer. Ann Surg 2005;242:212-223
14. Heriot AG, Tekkis PP, Fazio VW, et al. Adjuvant radiotherapy is associated with increased sexual dysfunction in male patients undergoing resection for rectal cancer: a predictive model. Ann Surg 2005;242:502-510
15. Kim NK, Aahn TW, Park JK, et al. Assessment of sexual and voiding function after total mesorectal excision with pelvic autonomic nerve preservation in males with rectal cancer. Dis Colon Rectum 2002;45:1178-1185 (Pubitemid 35051928)
16. Palmer G, Martling A, Lagergren P, et al. Quality of life after potentially curative treatment for locally advanced rectal cancer. Ann Surg Oncol 2008;15:3109-3117
17. Wilson TR, Alexander DJ. Clinical and non-clinical factors influencing postoperative health-related quality of life in patients with colorectal cancer. Br J Surg 2008;95:1408-1415
18. Swedish Rectal Cancer Trial. Local recurrence rate in a randomized multicentre trial of preoperative radiotherapy compared to surgery alone in resectable rectal carcinoma. Eur J Surg 1996;162:397-402 • This randomized trial showed that preoperative short-course preoperative radiation regimen reduced rates of local recurrence and improved survival among patients with resectable rectal cancer.
19. Camma C, Giunta M, Fiorica F, et al. Preoperative radiotherapy for resectable rectal cancer. A meta-analysis. JAMA 2000;248:1008-1015 • This meta-analysis showed that the combination of preoperative radiotherapy and surgery significantly improves local control and overall survival compared with surgery alone.
20. Kapiteijn E, Kranenbarg EK, Steup WH, et al. Total mesorectal excision (TME) with or without preoperative radiotherapy in the treatment of primary rectal cancer. Prespective randomised trial with standard operative and histopathological techniques. Dutch Colo Rectal Cancer Group. Eur J Surg 1999;165:410-420 • This randomized trial showed that preoperative short-course radiotherapy significantly decreased local recurrences compared with radical surgery with TME alone, but did not improve overall survival.
21. Sebag-Montefiore D, Stephens RJ, Steele R, et al. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet 2009;373:811-820
22. Weinstein GD, Rich TA, Shumate CR, et al. Preoperative infusional chemoradiation and surgery with or without an electron beam intraoperative boost for advanced primary rectal cancer. Int J Radiat Oncol Biol Phys 1995;32:197-204
23. Bujko K, Nowacki MP, Nasierowska-Guttmejer A, et al. Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy. Radiother Oncol 2004;72:15-24 (Pubitemid 38952855)
24. Bosset JF, Calais G, Daban A. Does the addition of chemotherapy to radiation increase acute toxicity in patients with rectal cancer: Report of 22921 EORTC phase III trial. J Clin Oncol 2003;21:294(abstr 1179) •• This randomized Phase III trial showed that combined CRT, given preoperatively or postoperatively, significantly decreased local recurrence and increased pCR rate, compared with RT alone, even though no impact on overall survival was observed.
25. Gérard JP, Conroy T, Bonnetain F, et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. J Clin Oncol 2006;24:4620-4625 •• This randomized trial showed that preoperative CRT significantly increased pCR rate and decreased local recurrence when compared with preoperative RT alone, but did not improve overall survival or disease-free survival.
26. Grann A, Feng C, Wong D, et al. Preoperative combined modality therapy for clinically resectable uT3 rectal adenocarcinoma. Int J Radiat Oncol Biol Phys 2001;49:987-995 (Pubitemid 32184605)
27. Rullier E, Goffre B, Bonell C. Preoperative radio-chemotherapy and sphincter saving resection in T3 carcinomas of the lower third of the rectum. Am Surg 2001;234:633-640 (Pubitemid 33041766)
28. Ruo L, Tikoo S, Klimstra D. Long term prognostic significance of extended rectal cancer response to preoperative radiation and chemotherapy. Am Surg 2002;236:75-81 (Pubitemid 34686453)
29. Roh M, Petrelli N, Wieand H. Phase III randomised trial of preoperative versus postoperative multimodality therapy in patients with carcinoma of the rectum (NSABP R-03). J Clin Oncol 2001;20(1):123(abstr 490)
30. Rouanet P, Rivoire M, Lelong B, et al. Sphincter preserving surgery after preoperative treatment for ultra-low rectal carcinoma. A French multicenter prospective trial: GERRCAR 1. J Clin Oncol 2006;24(18):152(abstr 3527)
31. Bujko K, Kepka L, Michalski W, et al. Does rectal cancer shrinkage induced by preoperative radio(chemo)therapy increase the likelihood of anterior resection? A systematic review of randomised trials. Radiother Oncol 2006;80:4-12 (Pubitemid 44236165)
32. Pahlman L, Glimelius B. Pre- or postoperative radiotherapy in rectal and rectosigmoid carcinoma. Report from a randomized multicenter trial. Ann Surg 1990;211:187-195 (Pubitemid 20188411)
33. Sauer R. Adjuvant versus neoadjuvant combined modality treatment for locally advanced rectal cancer: first results of the German rectal cancer study (CAO/ARO/ AIO-94). Int J Radiat Oncol Biol Phys 2003;57:124-125 •• Preoperative chemoradiotherapy, compared with postoperative chemoradiotherapy, improved local control and was associated with reduced toxicity but did not improve overall survival.
34. Francois Y, Nemoz CJ, Baulieux J, et al. Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial. J Clin Oncol 1999;17:2396-2402 (Pubitemid 29368238)
35. Stein DE, Mahmoud NN, Anne PR, et al. Longer time interval between completion of neoadjuvant chemoradiation and surgical resection does not improve downstaging of rectal carcinoma. Dis Colon Rectum 2003;46:448-453
36. Valentini V, Coco C, Cellini N, et al. Preoperative chemoradiation with cisplatin and 5-fluorouracil for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, sphincter preservation. Int J Radiat Oncol Biol Phys 1999;45:1175-1184
37. Rich TA, Shepard RC, Mosley ST. Four decades of continuing innovation with fluorouracil: current and future approaches to fluorouracil chemoradiation therapy. J Clin Oncol 2004;22:2214-2232
38. Byfield JE, Calabro-Jones P, Klisak I, et al. Pharmacologic requirements for obtaining sensitization of human tumor cells in vitro to combined 5-fluorouracilor ftorafur and X rays. Int J Radiat Oncol Biol Phys 1982;8:1923-1933 (Pubitemid 13167377)
39. Hartley A, Ho KF, McConkey C, et al. Pathological complete response following pre-operative chemoradiotherapy in rectal cancer: analysis of phase II/III trials. Br J Radiol 2005;78:934-938 (Pubitemid 41582245)
40. Schiessel R, Karner-Hanusch J, Herbst F, et al. Intersphincteric resection for low rectal tumours. Br J Surg 1994;81:1376-1378 (Pubitemid 24275179)
41. Chamlou R, Parc Y, Simon T, et al. Long-term results of intersphincteric resection for low rectal cancer. Ann Surg 2007;246:916-21; discussion 921-922 (Pubitemid 350179170)
42. Weiser MR, Quah HM, Shia J, et al. Sphincter preservation in low rectal cancer is facilitated by preoperative chemoradiation and intersphincteric dissection. Ann Surg 2009;249:236-242
43. Steele GD Jr, Herndon JE, Bleday R, et al. Sphincter-sparing treatment for distal rectal adenocarcinoma. Ann Surg Oncol 1999;6:433-441 (Pubitemid 29379560)
44. Peeters KC, Marijnen CA, Nagtegaal ID, et al. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg 2007;246:693-701
45. Gunderson LL, Sargent DJ, Tepper JE, et al. Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysis. J Clin Oncol 2004;22:1785-1796 •• In the pooled analysis, a progressive increase in T stage (T1-2 vs T3 vs T4) negatively impacted both survival and disease relapse. Within each T stage, substaging based on the amount of nodal involvement (N stages of N0, N1, N2) resulted in a decrease in both OS and DFS and an increase in both local and distant relapse rates.
46. Glimelius B. Chemoradiotherapy for rectal cancer - is there an optimal combination? Ann Oncol 2001;12:1039-1045
47. Rodel C, Martus P, Papadoupolos T, et al. Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol 2005;23:8688-8696 (Pubitemid 46211512)
48. Collette L, Bosset JF, den Dulk M, et al. Patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: does anybody benefit from adjuvant fluorouracil-based chemotherapy? A trial of the European Organisation for Research and Treatment of Cancer Radiation Oncology Group. J Clin Oncol 2007;25:4379-4386 (Pubitemid 350013843)
49. Dunst J, Reese T, Sutter T, et al. Phase I trial evaluating the concurrent combination of radiotherapy and capecitabine in rectal cancer. J Clin Oncol 2002;20:3983-3991
50. Gerard JP, Chapet O, Nemoz C, et al. Preoperative concurrent chemoradiotherapy in locally advanced rectal cancer with high-dose radiation and oxaliplatin-containing regimen: the Lyon R0-04 phase II trial. J Clin Oncol 2003;21:1119-1124 (Pubitemid 46594142)
51. Mohiuddin M, Winter K, Mitchell E, et al. Randomized phase II study of neoadjuvant combined modality chemoradiation for distal rectal cancer: Radiation Therapy Oncology Group trial 0012. J Clin Oncol 2006;24:650-655 (Pubitemid 46630429)
52. Aschele C, Pinto C, Rosati G, et al. Pre-operative FU-based chemoradiation +/- weekly oxaliplatin in locally advanced rectal cancer. Preliminary safety findings of the STAR (Studio Terapia Adiuvante Retto)-01 randomized trial. Proceedings of the 2007 Gastrointestinal Cancers Symposium of ASCO Orlando FL, 19-21 Jan 2007: abstract 233
53. Wong SJ, Winter K, Meropol NJ, et al. RTOG 0247: a randomized phase II study of neoadjuvant capecitabine and irinotecan versus capecitabine and oxaliplatin with concurrent radiation therapy for locally advanced rectal cancer [abstract 4021]. J Clin Oncol 2008;26(15S):183s
54. Williams K, Telfer B, Stratford I, et al. ZD1839, a specific oral epidermal growth factor receptor-tyrosine kinase inhibitor, potentiates radiotherapy in a human colorectal cancers xenograft model. Br J Cancer 2002;86:1157-1161 (Pubitemid 34438090)
55. Czito BG, Willett CG, Bendell JC, et al. Increased toxicity with gefitinib, capecitabine, and radiation therapy in pancreatic and rectal cancer: phase I trial results. J Clin Oncol 2006;24:656-662
56. Machiels JP, Sempoux C, Scalliet P, et al. Phase I/II study of preoperative cetuximab, capecitabine, and external beam radiotherapy in patients with rectal cancer. Ann Oncol 2007;18:738-744 (Pubitemid 46523279)
57. Willett CG, Kozin SV, Duda DG, et al. Combined vascular endothelial growth factor-targeted therapy and radiotherapy for rectal cancer: theory and clinical practice. Semin Oncol 2006;33(5 Suppl 10):S35-S40
58. Czito BG, Bendell JC, Willett CG, et al. Bevacizumab, oxaliplatin, and capecitabine with radiation therapy in rectal cancer: phase I trial results. Int J Radiat Oncol Biol Phys 2007;68:472-478 (Pubitemid 46694189)
59. Das P, Lin EH, Bhatia S, et al. Preoperative chemoradiotherapy with capecitabine versus protracted infusion 5-fluorouracil for rectal cancer: a matched-pair analysis. Int J Radiat Oncol Biol Phys 2006;66:1378-1383 (Pubitemid 44778959)
60. Rodel C, Arnold D, Hipp M, et al. Phase I-II trial of cetuximab, capecitabine, oxaliplatin, and radiotherapy as preoperative treatment in rectal cancer. Int J Radiat Oncol Biol Phys 2008;70:1081-1086 (Pubitemid 351296110)
61. Van Cutsem E, Lang I, D'haens G, et al. KRAS status and efficacy in the first-line treatment of patients with metastatic colorectal cancer (mCRC) treated with FOLFIRI with or without cetuximab: the CRYSTAL experience [abstract 2]. J Clin Oncol 2008;26(Suppl):5s
62. Cascini GL, Avallone A, Delrio P, et al. 18F-FDG PET is an early predictor of pathologic tumor response to preoperative radiochemotherapy in locally advanced rectal cancer. J Nucl Med 2006;47:1241-1248 (Pubitemid 47544874)
63. Available from: http://www.cancer.gov/ clinicaltrials/search [Last accessed 20 July 2009] •• The site contains all the information about onoing GCP trials.